MDS PODCAST: Defining Parkinson’s disease

Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders.

Subscribe

MDS Podcast What’s new in the pathophysiology of Parkinson’s disease? • 2024 MDS Congress

7 de octubre de 2024 casimedicos MDS PODCAST: Defining Parkinson's disease 0 Comments

Alpha-synuclein based biomarkers have dominated the Parksinon’s disease field over the past few years. Dr. Andrew Siderowf shares his views on the future of these biomarkers and what else the field may have in store.

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.